KALA BIO, Inc. SEC filings KALA

KALA BIO, Inc. has 675 filings in SEC EDGAR's recent list, going back to Dec 23, 2009. Its latest annual report, Form 10-K, was filed on Apr 15, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 19, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Nov 3, 2026 (shareholder vote results). The company's fiscal year ends on December 31.

KALA BIO, Inc. SEC filings
Form Description Filed Period
8-K Current report
Shareholder vote results
Nov 3, 2026 Nov 3, 2026
SCHEDULE 13G Ownership over 5% (passive) Oct 19, 2026 —
DEF 14A Proxy statement Sep 24, 2026 Nov 3, 2026
PRE 14A Preliminary proxy statement Sep 11, 2026 Sep 11, 2026
8-K Current report
Material agreement
Sep 10, 2026 Sep 3, 2026
8-K Current report
Other events
Sep 9, 2026 Sep 9, 2026
8-K Current report
Listing notice
Aug 28, 2026 Aug 27, 2026
10-Q Quarterly report Aug 19, 2026 Jun 30, 2026
NT 10-Q Filing Aug 14, 2026 Jun 30, 2026
8-K Current report
Other events
Jul 23, 2026 Jul 22, 2026
424B5 Prospectus supplement Jul 22, 2026 —
SCHEDULE 13D/A Amended ownership over 5% (active) Jul 2, 2026 —
EFFECT Filing Jun 25, 2026 —
S-3/A Filing Jun 12, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) May 15, 2026 —
10-Q Quarterly report May 15, 2026 Mar 31, 2026
S-3 Shelf registration May 7, 2026 —
8-K Current report
Change to shareholder rights, Bylaw or fiscal year change, Other events
May 7, 2026 May 7, 2026
10-K Annual report Apr 15, 2026 Dec 31, 2025
NT 10-K Filing Mar 31, 2026 Dec 31, 2025
D Filing Mar 17, 2026 —
144 Notice of proposed sale Mar 17, 2026 —
144 Notice of proposed sale Mar 12, 2026 —
144 Notice of proposed sale Mar 12, 2026 —
8-K Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
Mar 4, 2026 Mar 3, 2026
8-K Current report
Officer or director change
Feb 20, 2026 Feb 16, 2026
EFFECT Filing Feb 17, 2026 —
424B3 Prospectus Feb 17, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 17, 2026 —
CORRESP Letter to the SEC Feb 13, 2026 —
UPLOAD Letter from the SEC Feb 13, 2026 —
D Filing Feb 13, 2026 —
S-3 Shelf registration Feb 10, 2026 —
3 Initial insider ownership Feb 9, 2026 Jan 30, 2026
3 Initial insider ownership Feb 9, 2026 Jan 30, 2026
3 Initial insider ownership Feb 9, 2026 Jan 30, 2026
3 Initial insider ownership Feb 9, 2026 Jan 30, 2026
3 Initial insider ownership Feb 9, 2026 Jan 30, 2026
SCHEDULE 13D Ownership over 5% (active) Feb 6, 2026 —
8-K Current report
Officer or director change
Feb 5, 2026 Feb 2, 2026
8-K Current report
Material agreement, Unregistered share sale, Change in control, Officer or director change, Bylaw or fiscal year change, Shareholder vote results
Feb 2, 2026 Jan 30, 2026
DEFA14A Additional proxy material Jan 26, 2026 —
8-K Current report
Listing notice
Jan 23, 2026 Jan 20, 2026
SCHEDULE 13G Ownership over 5% (passive) Jan 13, 2026 —
8-K Current report
Material agreement
Jan 8, 2026 Jan 8, 2026
424B5 Prospectus supplement Jan 8, 2026 —
DEFA14A Additional proxy material Jan 6, 2026 —
8-K Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
Jan 6, 2026 Dec 30, 2025
8-K Current report
Other events
Jan 2, 2026 Dec 26, 2025
DEF 14A Proxy statement Dec 30, 2025 Jan 30, 2026
8-K Current report
Auditor change, Officer or director change
Dec 29, 2025 Dec 19, 2025
4 Insider transaction Dec 22, 2025 Dec 18, 2025
PRER14A Filing Dec 19, 2025 —
8-K Current report
Auditor change
Dec 16, 2025 Dec 15, 2025
8-K Current report
Other events
Dec 16, 2025 Dec 16, 2025
8-K Current report
Material agreement, Other events
Dec 5, 2025 Dec 4, 2025
424B5 Prospectus supplement Dec 5, 2025 —
3 Initial insider ownership Dec 3, 2025 Nov 25, 2025
SCHEDULE 13G Ownership over 5% (passive) Dec 3, 2025 —
3/A Form 3/a Dec 2, 2025 Nov 23, 2025
4 Insider transaction Nov 26, 2025 Nov 24, 2025
3 Initial insider ownership Nov 26, 2025 Nov 24, 2025
8-K Current report
Material agreement, Agreement ended, New debt, Unregistered share sale, Officer or director change, Bylaw or fiscal year change
Nov 25, 2025 Nov 20, 2025
10-Q Quarterly report Nov 19, 2025 Sep 30, 2025
NT 10-Q Filing Nov 14, 2025 Sep 30, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Nov 14, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Nov 14, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Nov 14, 2025 —
8-K Current report
Listing notice
Nov 12, 2025 Nov 10, 2025
8-K Current report
Material agreement, New debt, Unregistered share sale, Other events
Nov 10, 2025 Nov 9, 2025
4 Insider transaction Oct 24, 2025 Oct 23, 2025
4 Insider transaction Oct 24, 2025 Oct 22, 2025
4 Insider transaction Oct 24, 2025 Oct 22, 2025
4 Insider transaction Oct 24, 2025 Oct 22, 2025
4 Insider transaction Oct 24, 2025 Oct 22, 2025
144 Notice of proposed sale Oct 23, 2025 —
144 Notice of proposed sale Oct 23, 2025 —
144 Notice of proposed sale Oct 22, 2025 —
144 Notice of proposed sale Oct 22, 2025 —
144 Notice of proposed sale Oct 22, 2025 —
144 Notice of proposed sale Oct 22, 2025 —
8-K Current report
Exit or restructuring costs, Officer or director change, Other events
Oct 20, 2025 Oct 19, 2025
SCHEDULE 13D/A Amended ownership over 5% (active) Oct 15, 2025 —
SCHEDULE 13G Ownership over 5% (passive) Oct 3, 2025 —
SCHEDULE 13D/A Amended ownership over 5% (active) Oct 2, 2025 —
4 Insider transaction Oct 2, 2025 Sep 30, 2025
8-K/A Amended current report
Exit or restructuring costs, Officer or director change
Oct 2, 2025 Sep 28, 2025
SCHEDULE 13D/A Amended ownership over 5% (active) Oct 1, 2025 —
8-K Current report Oct 1, 2025 Sep 29, 2025
8-K Current report
Exit or restructuring costs, Other events
Sep 29, 2025 Sep 28, 2025
8-K Current report
Other events
Sep 18, 2025 Sep 16, 2025
SCHEDULE 13G Ownership over 5% (passive) Sep 11, 2025 —
SCHEDULE 13G Ownership over 5% (passive) Sep 11, 2025 —
4 Insider transaction Sep 2, 2025 Aug 29, 2025
8-K Current report
Officer or director change
Sep 2, 2025 Aug 29, 2025
10-Q Quarterly report Aug 8, 2025 Jun 30, 2025
8-K Current report
Results of operations
Aug 8, 2025 Aug 8, 2025
8-K Current report
Other events
Jul 9, 2025 Jul 9, 2025
4 Insider transaction Jun 26, 2025 Jun 24, 2025
4 Insider transaction Jun 26, 2025 Jun 24, 2025
4 Insider transaction Jun 26, 2025 Jun 24, 2025
4 Insider transaction Jun 26, 2025 Jun 24, 2025
4 Insider transaction Jun 26, 2025 Jun 24, 2025
144 Notice of proposed sale Jun 24, 2025 —
144 Notice of proposed sale Jun 24, 2025 —
144 Notice of proposed sale Jun 24, 2025 —
144 Notice of proposed sale Jun 24, 2025 —
144 Notice of proposed sale Jun 24, 2025 —
4 Insider transaction Jun 17, 2025 Jun 15, 2025
4 Insider transaction Jun 17, 2025 Jun 15, 2025
4 Insider transaction Jun 17, 2025 Jun 15, 2025
4 Insider transaction Jun 17, 2025 Jun 15, 2025
4 Insider transaction Jun 17, 2025 Jun 15, 2025
4 Insider transaction Jun 17, 2025 Jun 15, 2025
4/A Ownership document Jun 5, 2025 Jun 3, 2025
4 Insider transaction Jun 4, 2025 Jun 3, 2025
4 Insider transaction Jun 4, 2025 Jun 3, 2025
4 Insider transaction Jun 4, 2025 Jun 3, 2025
4 Insider transaction Jun 4, 2025 Jun 3, 2025
4 Insider transaction Jun 4, 2025 Jun 3, 2025
144 Notice of proposed sale Jun 3, 2025 —
10-Q Quarterly report May 14, 2025 Mar 31, 2025
8-K Current report
Results of operations
May 14, 2025 May 14, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) May 12, 2025 —
8-K Current report
Officer or director change
Apr 11, 2025 Apr 10, 2025
424B5 Prospectus supplement Mar 31, 2025 —
10-K Annual report Mar 31, 2025 Dec 31, 2024
8-K Current report
Results of operations
Mar 31, 2025 Mar 31, 2025
4 Insider transaction Mar 10, 2025 Mar 7, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 14, 2025 —
SCHEDULE 13G Ownership over 5% (passive) Feb 14, 2025 —
8-K Current report
Officer or director change
Feb 12, 2025 Feb 11, 2025
EFFECT Filing Feb 4, 2025 —
424B3 Prospectus Feb 4, 2025 —
CORRESP Letter to the SEC Jan 31, 2025 —
UPLOAD Letter from the SEC Jan 31, 2025 —
S-3 Shelf registration Jan 24, 2025 —
4/A Filing Jan 10, 2025 Jan 6, 2025
4 Insider transaction Jan 7, 2025 Jan 6, 2025
4 Insider transaction Jan 7, 2025 Jan 6, 2025
4 Insider transaction Jan 7, 2025 Jan 6, 2025
4 Insider transaction Jan 7, 2025 Jan 6, 2025
4 Insider transaction Jan 7, 2025 Jan 6, 2025
144 Notice of proposed sale Jan 6, 2025 —
S-8 Employee stock plan registration Jan 3, 2025 —
SCHEDULE 13D/A Amended ownership over 5% (active) Dec 31, 2024 —
D Filing Dec 31, 2024 —
4 Insider transaction Dec 31, 2024 Dec 30, 2024
8-K Current report
Material agreement, Unregistered share sale, Bylaw or fiscal year change, Other events
Dec 30, 2024 Dec 29, 2024
SC 13G Ownership over 5% (passive) Nov 14, 2024 —
10-Q Quarterly report Nov 12, 2024 Sep 30, 2024
8-K Current report
Results of operations
Nov 12, 2024 Nov 12, 2024
8-K Current report
Officer or director change
Sep 25, 2024 Sep 23, 2024
424B5 Prospectus supplement Sep 6, 2024 —
10-Q Quarterly report Aug 6, 2024 Jun 30, 2024
8-K Current report
Results of operations
Aug 6, 2024 Aug 6, 2024
EFFECT Filing Jul 31, 2024 —
424B3 Prospectus Jul 31, 2024 —
CORRESP Letter to the SEC Jul 29, 2024 —
UPLOAD Letter from the SEC Jul 26, 2024 —
S-3 Shelf registration Jul 25, 2024 —
144 Notice of proposed sale Jul 17, 2024 —
144 Notice of proposed sale Jul 16, 2024 —
SC 13D Ownership over 5% (active) Jul 8, 2024 —
D Filing Jun 28, 2024 —
SC 13D Ownership over 5% (active) Jun 28, 2024 —
3 Initial insider ownership Jun 28, 2024 Jun 28, 2024
4 Insider transaction Jun 27, 2024 Jun 26, 2024
4 Insider transaction Jun 27, 2024 Jun 26, 2024
4 Insider transaction Jun 27, 2024 Jun 26, 2024
4 Insider transaction Jun 27, 2024 Jun 26, 2024
4 Insider transaction Jun 27, 2024 Jun 26, 2024
8-K Current report
Material agreement, Unregistered share sale, Bylaw or fiscal year change, Other events
Jun 27, 2024 Jun 26, 2024
144 Notice of proposed sale Jun 24, 2024 —
144 Notice of proposed sale Jun 24, 2024 —
144 Notice of proposed sale Jun 24, 2024 —
144 Notice of proposed sale Jun 24, 2024 —
144 Notice of proposed sale Jun 24, 2024 —
4 Insider transaction Jun 12, 2024 Jun 11, 2024
4 Insider transaction Jun 12, 2024 Jun 11, 2024
4 Insider transaction Jun 12, 2024 Jun 11, 2024
4 Insider transaction Jun 12, 2024 Jun 11, 2024
4 Insider transaction Jun 12, 2024 Jun 11, 2024
4 Insider transaction Jun 12, 2024 Jun 11, 2024
8-K Current report
Shareholder vote results
Jun 12, 2024 Jun 11, 2024
4 Insider transaction Jun 3, 2024 May 31, 2024
4 Insider transaction Jun 3, 2024 May 31, 2024
4 Insider transaction Jun 3, 2024 May 31, 2024
4 Insider transaction Jun 3, 2024 May 31, 2024
4 Insider transaction Jun 3, 2024 May 31, 2024
144 Notice of proposed sale May 31, 2024 —
DEFA14A Additional proxy material May 30, 2024 —
10-Q Quarterly report May 14, 2024 Mar 31, 2024
8-K Current report
Results of operations
May 14, 2024 May 14, 2024
ARS Annual report to shareholders Apr 29, 2024 Dec 31, 2023
DEFA14A Additional proxy material Apr 29, 2024 —
DEF 14A Proxy statement Apr 29, 2024 Jun 11, 2024
PRE 14A Preliminary proxy statement Apr 19, 2024 Jun 11, 2024
424B5 Prospectus supplement Mar 29, 2024 —
S-8 Employee stock plan registration Mar 29, 2024 —

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
KALA (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Arlington, MA
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1479419
Former names
KALA BIO, Inc. (until Nov 3, 2026); Kala Pharmaceuticals, Inc. (until Jun 23, 2023)

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.